Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy

Abstract Quantitative proteomics of postmortem human brain can identify dysfunctional proteins that contribute to neurodegenerative disorders like Alzheimer disease (AD) and frontotemporal dementia. Similar studies in chronic traumatic encephalopathy (CTE) are limited, therefore we hypothesized that...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuropathology and experimental neurology Vol. 77; no. 1; pp. 40 - 49
Main Authors: Cherry, Jonathan D, Zeineddin, Ahmad, Dammer, Eric B, Webster, James A, Duong, Duc, Seyfried, Nicholas T, Levey, Allan I, Alvarez, Victor E, Huber, Bertrand R, Stein, Thor D, Kiernan, Patrick T, McKee, Ann C, Lah, James J, Hales, Chadwick M
Format: Journal Article
Language:English
Published: England Oxford University Press 01-01-2018
by American Association of Neuropathologists, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Quantitative proteomics of postmortem human brain can identify dysfunctional proteins that contribute to neurodegenerative disorders like Alzheimer disease (AD) and frontotemporal dementia. Similar studies in chronic traumatic encephalopathy (CTE) are limited, therefore we hypothesized that proteomic sequencing of CTE frontal cortex brain homogenates from varying CTE pathologic stages may provide important new insights into this disorder. Quantitative proteomics of control, CTE and AD brains was performed to characterize differentially expressed proteins, and we identified over 4000 proteins in CTE brains, including significant enrichment of the microtubule associated protein tau. We also found enrichment and pathologic aggregation of RNA processing factors as seen previously in AD, supporting the previously recognized overlap between AD and CTE. In addition to these similarities, we identified CTE-specific enrichment of proteins which increase with increasing severity of CTE pathology. NADPH dehydrogenase quinone 1 (NQO1) was one of the proteins which showed significant enrichment in CTE and also correlated with increasing CTE stage. NQO1 demonstrated neuropathologic correlation with hyperphosphorylated tau in glial cells, mainly astrocytes. These results demonstrate that quantitative proteomic analysis of CTE postmortem human brain can identify disease relevant findings and novel cellular pathways involved in CTE pathogenesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Supplementary Data can be found at http://www.jnen.oxfordjournals.org.
The authors have no duality or conflicts of interest to declare.
This study was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038) to T.D.S.; Alzheimer’s Association (NIRG-305779) to T.D.S.; Veterans Affairs Biorepository (CSP 501) to T.D.S. and A.C.M.; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C) to A.C.M.; National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01) to J.D.C., V.E.A., B.R.H., P.T.K., T.D.S., and A.C.M.; National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5) to T.D.S. and A.C.M.; Alzheimer’s Association (AARF-17-529888) to J.D.C.; Department of Defense Peer Reviewed Alzheimer’s Research Program (DoD-PRARP #13267017) to A.C.M.; Concussion Legacy Foundation to A.C.M.; Accelerating Medicine Partnership AD grant U01AG046161-02 to A.I.L., the NINDS Emory Neuroscience and Proteomics Core (P30NS055077) A.I.L., the Emory Alzheimer’s Disease Research Center (P50AG025688) to A.I.L., NINDS K08NS087121 to CMH and DoD-PRARP AZ150143 to C.M.H. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
ISSN:0022-3069
1554-6578
DOI:10.1093/jnen/nlx100